Strength in Knee Replacement and Sports Medicine Drives Smith+Nephew Growth

Smith+Nephew reported 3Q19 orthopedic revenue of USD $852 million, +4.7% vs. 3Q18.

Updated 2019 full year guidance to the range of $5,095.3 million (+3.9%) to $5,144.3 million (+4.9%)
Knees and hips rebounded after a soft 2Q19, assisted by double-digit year over year growth from NAVIO and assets acquired from Brainlab in May...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us